Who is sponsoring NCT04628949?

NCT04628949 is sponsored by Ambu A/S.

What drugs are being tested in NCT04628949?

Interventions in NCT04628949: aScope™ Duodeno endoscope and aBox™ Duodeno.

What condition does NCT04628949 study?

NCT04628949 studies Endoscopic Retrograde Cholangiopancreatography (ERCP).

Is NCT04628949 still recruiting?

NCT04628949 is currently completed. Last updated 1 August 2022.

Last reviewed 2022-08-01 · How we verify

NCT04628949

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Single-Use Duodenoscope in a Real-World Setting

Completed NA Last updated 1 August 2022

What this trial tests

NA trial testing aScope™ Duodeno endoscope and aBox™ Duodeno in Endoscopic Retrograde Cholangiopancreatography (ERCP) in 248 participants. Completed in 28 February 2022.

Timeline

25 January 2021

Primary endpoint
27 January 2022

28 February 2022

Quick facts

Lead sponsor	Ambu A/S
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	248
Start date	25 January 2021
Primary completion	27 January 2022
Estimated completion	28 February 2022
Sites	9 locations across United States

Drugs / interventions tested

aScope™ Duodeno endoscope and aBox™ Duodeno

Conditions studied

Endoscopic Retrograde Cholangiopancreatography (ERCP) — all drugs for Endoscopic Retrograde Cholangiopancreatography (ERCP) →

Sponsor

Ambu A/S — full company profile →

Who can join

18 and older, any sex, with Endoscopic Retrograde Cholangiopancreatography (ERCP). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess how the aScope™ Duodeno endoscope performs in procedures that treat problems of the bile and pancreatic ducts.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Single-use duodenoscopes for the prevention of endoscopic retrograde cholangiopancreatography -related cross-infection - from bench studies to clinical evidence.
Lisotti A, Fusaroli P, Napoleon B, Cominardi A, et al · · 2022 · PMID 35721249 · DOI 10.5662/wjm.v12.i3.122

Verify or expand the search:

Other recruiting trials for Endoscopic Retrograde Cholangiopancreatography (ERCP)

Currently open trials in the same condition.

NCT07017283 — Effect of Deep Analgosedation vs. Endotracheal Intubation General Anesthesia on on Perioperative Sedation Related Advers · NA · recruiting

Other Ambu A/S trials

Trials by the same sponsor.

NCT06465797 — Observational Bronchoscopy Video Data Collection Study With Adult Patients · completed
NCT05198219 — Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults · NA · unknown
NCT04190641 — Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder · NA · completed
NCT04192474 — Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy · NA · completed
NCT04128527 — AuraOnce Performance Observation · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04628949 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ambu A/S
Last refreshed: 1 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04628949.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing